retatrutide phase 2 type 2 diabetes trial Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, 3 Retatrutide Helped Adults With Diabetes

Arthritis care & research, 64(10), 1431-1446

Our quality assurance program includes High-Performance Liquid Chromatography (HPLC) to confirm peptide identity and purity at 99%, and Mass Spectrometry (MS) to verify molecular weight matches the expected 403.93 Da, confirming correct amino acid sequence and copper complexation

This compounded preparation uses the same active pharmaceutical ingredient (semaglutide) prepared by Genesis Compounding with cyanocobalamin as a patient-specific 503A product

IGF-1 contains three disulphide bridges, between amino acids 6 and 48, 18 and 61 and 47 and 52, which create the tertiary structure critical for optimum binding to the IGF-1R (Figure 1)

Press a cotton ball or gauze over the injection site if blood appears

Every compounded dose of semaglutide undergoes potency and purity testing before shipment